BioCryst Pharmaceuticals, Inc. (BCRX) vs Immunome, Inc. (IMNM)
A side-by-side comparison of BioCryst Pharmaceuticals, Inc. and Immunome, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
BCRX
BioCryst Pharmaceuticals, Inc.
$8.15HealthcareDelayed quote: Oct 6, 2026, 9:30 AM EDT
IMNM
Immunome, Inc.
$21.17HealthcareDelayed quote: Oct 5, 2026, 4:00 PM EDT
Total return — BCRX vs IMNM
growth of $100 · dividends reinvested · last 6yBCRX +136.2% (+15.4%/yr)IMNM +57.4% (+7.9%/yr)BCRX compounded faster over this window
BCRX IMNM
BCRX vs IMNM: by the numbers
- •BCRX is the larger company ($2.07B vs $2.02B market cap).
- •Both run net losses; BCRX's is the smaller (-40.90% vs -3059.99% net margin).
Metrics side by side
Valuation
| Metric | BCRX | IMNM |
|---|---|---|
| P/S ratio | 2.20 | N/A |
| P/B ratio | N/A | 3.85 |
| FCF yield | 17.24% | N/A |
Profitability
| Metric | BCRX | IMNM |
|---|---|---|
| Gross margin | 97.82% | 57.43% |
| Operating margin | 38.98% | -3084.76% |
| Net margin | -40.90% | -3059.99% |
| ROE | N/A | -48.43% |
| ROIC | -89.73% | -51.06% |
Growth (annualized)
| Metric | BCRX | IMNM |
|---|---|---|
| Revenue CAGR (5Y) | 64.07% | N/A |
| Total return CAGR (5Y) | -10.02% | 2.88% |
Frequently asked
- How have BCRX and IMNM total returns compared?
- Over the past 5 years, BCRX delivered -10.02% and IMNM delivered 2.88% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
BioCryst Pharmaceuticals ROEImmunome ROEBioCryst Pharmaceuticals operating marginImmunome operating marginBioCryst Pharmaceuticals revenue growthImmunome revenue growthBioCryst Pharmaceuticals free cash flowImmunome free cash flow
BioCryst Pharmaceuticals & Immunome appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.